Companies: 10,795·Total market cap: $144.5T
Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited

RDYNYSEHealthcare● Active
$13.33
+$0.09(+0.64%)
Market Cap$11.1B
P/E Ratio—
52W High$16.17
52W Low$12.19
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Dr. Reddy's Laboratories Limited (RDY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001135951 · RDY · NYSE · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
2001
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001135951 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-05-29
Fiscal Year End
May 29, 2026
Accession No.
0001575872-26-000381
Primary Document
rdy0899_20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001135951 · Accession 0001575872-26-000381

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-05
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-05
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-01
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-05-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
Showing 1–15 of 996 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001135951  |  Exchange: NYSE · Healthcare

Dr. Reddy's Laboratories Limited (NYSE: RDY) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2001. As a Healthcare sector company with CIK 0001135951, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Dr. Reddy's Laboratories Limited's most comprehensive regulatory disclosure. The most recent Dr. Reddy's Laboratories Limited 10-K was filed on 2026-05-29 for fiscal year ending 2026. Historical RDY 10-K annual reports are available from 2015 through 2026.

Investors researching Dr. Reddy's Laboratories Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RVMD SEC Filings →VTRS SEC Filings →NBIX SEC Filings →SOLV SEC Filings →EXEL SEC Filings →ELAN SEC Filings →RVTY SEC Filings →BMRN SEC Filings →
→ RDY Financials→ RDY Earnings→ RDY Insider Trades

Frequently Asked Questions

RDY SEC Filings · 8 questions

Dr. Reddy's Laboratories Limited (RDY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Dr. Reddy's Laboratories Limited's CIK is 0001135951.

RDY SEC filingsDr. Reddy's Laboratories Limited SEC documentsfind RDY 10-K